基本信息
浏览量:307
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Alexander Marcus Seifalian (AMS)whois Professor of Nanotechnology and Regenerative Medicine and Head of Department with a multidisciplinary background from nuclear physics to physiology, nanotechnology, biomaterials, interaction of cells with nanocomposite materials as well as working on stem cells. He is based in Division of Surgery and Interventional Science.
He is Fellow of the Institute of Nanotechnology (FIoN) and Society of Biology (FSB), and has published over 460 peer-reviewed articles, 41 book chapters and 10 international patents. His current projects have led to the development of cardiovascular implants using nanomaterials and stem cell technology, development of organs using tissue engineering and nanoparticles for the detection and treatment of cancer. He was awarded the top prize in the field of nanomaterials for cardiovascular implants in 2007 by Medical Future Innovation, and in 2009 received a Business Innovation Award from UK Trade & Investment (UKTI) in the Life Sciences and Healthcare Category. He received the most innovative new product award in 2012 for the ‘synthetic trachea’ by European Life Science, Hamburg, Germany, andin 2013 was acknowledged by the international community for his outstanding achievements in Nanoscience and Nanotechnology with the prestigious Nanosmat prize award in Granada, Spain. AMS has a significant track record with regard to generating impact through the translation of technology from the laboratory directly to the clinic, and has demonstrated that nanocomposite polymers are core to the next generation of surgical implants with highly successful outcomes in a number of pioneering projects. This led to the development of the world’s firstsynthetic trachea, nasal and ear reconstruction, lacrimal duct conduit, and small diameter bypass grafts for coronary artery and vascular replacement, which has enter clinical trials, all of which have been used as first-in-man. His experience in translational research has led to a number of cutting edge projects at various stages of development. For example, we have developed abdominal aortic aneurysm(AAA) stent-grafts, cardiac patches and transcatheter heart valves at the pre-clinical stage.
During his career he has led many large projects with multidisciplinary teams composed of scientists, engineers, and clinicians in collaboration with UK industry,all with very successful outcomes in terms of commercialisation and translation to benefit patient healthcare including;i) commercialisation of bypass grafts for vascular access and haemodialysis; and ii) development of laser activated vascular sealants, which have been commercialised, and many others medical devices currently in development.
He is Fellow of the Institute of Nanotechnology (FIoN) and Society of Biology (FSB), and has published over 460 peer-reviewed articles, 41 book chapters and 10 international patents. His current projects have led to the development of cardiovascular implants using nanomaterials and stem cell technology, development of organs using tissue engineering and nanoparticles for the detection and treatment of cancer. He was awarded the top prize in the field of nanomaterials for cardiovascular implants in 2007 by Medical Future Innovation, and in 2009 received a Business Innovation Award from UK Trade & Investment (UKTI) in the Life Sciences and Healthcare Category. He received the most innovative new product award in 2012 for the ‘synthetic trachea’ by European Life Science, Hamburg, Germany, andin 2013 was acknowledged by the international community for his outstanding achievements in Nanoscience and Nanotechnology with the prestigious Nanosmat prize award in Granada, Spain. AMS has a significant track record with regard to generating impact through the translation of technology from the laboratory directly to the clinic, and has demonstrated that nanocomposite polymers are core to the next generation of surgical implants with highly successful outcomes in a number of pioneering projects. This led to the development of the world’s firstsynthetic trachea, nasal and ear reconstruction, lacrimal duct conduit, and small diameter bypass grafts for coronary artery and vascular replacement, which has enter clinical trials, all of which have been used as first-in-man. His experience in translational research has led to a number of cutting edge projects at various stages of development. For example, we have developed abdominal aortic aneurysm(AAA) stent-grafts, cardiac patches and transcatheter heart valves at the pre-clinical stage.
During his career he has led many large projects with multidisciplinary teams composed of scientists, engineers, and clinicians in collaboration with UK industry,all with very successful outcomes in terms of commercialisation and translation to benefit patient healthcare including;i) commercialisation of bypass grafts for vascular access and haemodialysis; and ii) development of laser activated vascular sealants, which have been commercialised, and many others medical devices currently in development.
研究兴趣
论文共 773 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
International journal of biological macromolecules (2024): 128917-128917
Nanoscaleno. 27 (2024): 12793-12819
Zeinab Hajmohammadi,Zohreh Bagher, Farzad Taghizadeh-Hesary, Mahboobe Khodadadi, Niki Masror, Alimohamad Asghari, Behnaz Valipour,Alexander Seifalian
European Journal of Pharmaceutics and Biopharmaceutics (2024): 114393
JOURNAL OF NON-CRYSTALLINE SOLIDS (2024): 122909
Zeinab Hajmohammadi,Zohreh Bagher, Farzad Taghizadeh-Hesary, Mahboobe Khodadadi, Niki Masror,Alimohamad Asghari,Behnaz Valipour,Alexander Seifalian
Scientific reportsno. 1 (2024): 13362-13362
Amel Ibrahim,Oliver FW Gardner, Naira Rodriguez-Florez,John C Hutchinson,Alexander Seifalian, Daniel Thomas-Vazque, Neil J Sebire,David Dunaway,Neil W Bulstrode,Patrizia Ferretti
Biofunctional Materials (2024)
加载更多
作者统计
#Papers: 769
#Citation: 38642
H-Index: 92
G-Index: 163
Sociability: 7
Diversity: 5
Activity: 102
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn